IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Alzamend Neuro Inc (ALZN)

CUSIP: 02262M605 | NYSE | Healthcare · Biotechnology | Micro Cap | 22 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AMilton C. Ault, III
with Hyperscale Data, Inc., Ault Lending, LLC, Ault Life Sciences, Inc., +5 more
166,9094.4%−139,412Oct 3, 2025No 13F filer matched
13D/A

Institutional Holders — Q3 2026

Kingsbury Capital Investment Advisors LLC1,119,932
1.8% of portfolio›$1.9M
SBI Securities Co., Ltd.22
0.0% of portfolio›$38
Caitong International Asset Management Co., Ltd4
0.0% of portfolio›$7
Harbor Investment Advisory, LLC1
0.0% of portfolio›$2
StyleTurnoverLocationFiled
Kingsbury Capital Investment Advisors LLC
1,119,932$1.9M1.8%GrowthMediumEvanston, IL2026-10-20
SBI Securities Co., Ltd.
22$380.0%Agg GrowthLowTokyo, Mexico2026-10-22
Caitong International Asset Management Co., Ltd
4$70.0%GrowthVery HighHong Kong, South Korea2026-10-29
Harbor Investment Advisory, LLC
1$20.0%GrowthLowLutherville, MD2026-10-13
Milton C. Ault, III
166,909
4.4% of class · Oct 3, 2025−139,412
with Hyperscale Data, Inc., Ault Lending, LLC, Ault Life Sciences, Inc., +5 more
No 13F filer matched